XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue $ 578,000 $ 872,000 $ 1,815,000 $ 2,866,000
Cost of revenues 499,000 648,000 1,619,000 2,244,000
Gross profit 79,000 224,000 196,000 622,000
Operating expenses:        
Research and development 38,000 5,000 153,000 16,000
Sales and marketing 66,000 81,000 177,000 241,000
General and administrative 1,047,000 977,000 3,140,000 3,723,000
Amortization 0 86,000 0 259,000
Impairment charges 0 0 0 2,000
Casualty gain (insurance proceeds) 0 0 0 (400,000)
Total operating expenses 1,151,000 1,149,000 3,470,000 3,841,000
Operating loss (1,072,000) (925,000) (3,274,000) (3,219,000)
Interest income, net (32,000) (30,000) (124,000) (94,000)
Loss before income taxes (1,040,000) (895,000) (3,150,000) (3,125,000)
Income tax expense 0 0 9,000 38,000
Net loss (1,040,000) (895,000) (3,159,000) (3,163,000)
Preferred stock dividends 12,000 133,000 76,000 282,000
Warrants, deemed dividend 8,974,000 0 8,974,000 0
Warrant modification 0 0 0 25,000
Induced conversion of warrants 0 0 0 751,000
Net loss attributable to common stockholders $ (10,026,000) $ (1,028,000) $ (12,209,000) $ (4,221,000)
Net loss attributable to common stockholders per share:        
Basic and diluted net loss per share (in dollars per share) $ (11.25) $ (4.22) $ (16.6) $ (18.34)
Weighted-average number of shares of common stock:        
Basic and diluted (in shares) 890,943 243,378 735,286 230,214